Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03835039 · ClinicalTrials.gov registry record
The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy
A clinical trial, sponsored by Albany Medical College.
- Terminated
- Registry status
- 101
- Enrollment target
NCT03835039 is a clinical trial that was terminated before completion, run by Albany Medical College. The registered enrollment target is 101 participants.
The verdict
NCT03835039 was terminated before completion, sponsored by Albany Medical College.
- TERMINATED
- Registry status
- 101 participants
- Enrollment target
Study Summary
A longitudinal study evaluating the predictive ability of near infrared spectroscopy to predict brain injury in infants with hypoxic ischemic encephalopathy. Data will be analyzed at two different time periods, at discharge and again at 2 years of age.
Interventions
- DEVICE NIRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2019-01-03 |
| Est. Completion | 2022-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03835039
The ClinicalTrials.gov registry entry for NCT03835039 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NIRS is the first listed.
NCT03835039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03835039 about?
NCT03835039 is a clinical study titled "The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy". A longitudinal study evaluating the predictive ability of near infrared spectroscopy to predict brain injury in infants with hypoxic ischemic encephalopathy. Data will be analyzed at two different time periods, at discharge and again at 2 years of age.
What is the current status of trial NCT03835039?
This trial is currently terminated. The enrollment target is 101 participants. The study started on 2019-01-03. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT03835039?
The interventions under investigation include: NIRS (DEVICE).
Who is sponsoring clinical trial NCT03835039?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.